Skip to main content
ATEX
NASDAQ Technology

Anterix Chief Legal Officer Sells $1.44M in Stock Following Option Exercise

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
7
Price
$80
Mkt Cap
$1.483B
52W Low
$17.58
52W High
$88.12
Market data snapshot near publication time

Summary

Anterix's Chief Legal Officer sold over $1.44 million in company stock on the open market after exercising options, reducing her direct holdings.


Key Events

  • Officer Sells Shares

    Chief Legal Officer Gena L. Ashe sold 17,711 shares of Anterix common stock for approximately $1.44 million in open market transactions.

  • Option Exercise Precedes Sale

    The sale followed the exercise of options to acquire 29,368 shares for $1.29 million.

  • Tax Withholding

    An additional 15,657 shares, valued at $1.29 million, were disposed of to cover tax obligations related to the option exercise.

  • Reduced Holdings

    Post-transaction, Ms. Ashe's direct holdings decreased to 42,899 shares.


Analysis

Anterix's Chief Legal Officer, Gena L. Ashe, sold over $1.44 million worth of company stock on the open market. While the transaction involved an option exercise and subsequent tax withholding, the discretionary open market sale component represents a notable reduction in direct ownership by an officer. This transaction contributes to the ongoing pattern of insider distribution observed over the last 90 days.

At the time of this filing, ATEX was trading at $80.00 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $17.58 to $88.12. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ATEX - Latest Insights

ATEX
Jun 17, 2026, 7:10 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $80.00
Real-time Price: $80.00 info
Change: $0 (0%) info
Market Cap: $1.483B info
ATEX
Jun 15, 2026, 4:51 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $83.01
Real-time Price: $80.00 info
Change: -$3.01 (-4%) info
Market Cap: $1.483B info
ATEX
Jun 10, 2026, 5:00 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $65.00
Real-time Price: $80.00 info
Change: +$15.00 (+23%) info
Market Cap: $1.483B info
ATEX
Jun 10, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $67.77
Real-time Price: $80.00 info
Change: +$12.23 (+18%) info
Market Cap: $1.483B info
ATEX
May 18, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $56.80
Real-time Price: $80.00 info
Change: +$23.20 (+41%) info
Market Cap: $1.483B info
ATEX
Apr 21, 2026, 9:16 AM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $42.60
Real-time Price: $80.00 info
Change: +$37.40 (+88%) info
Market Cap: $1.483B info
ATEX
Apr 17, 2026, 4:09 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $42.19
Real-time Price: $80.00 info
Change: +$37.81 (+90%) info
Market Cap: $1.483B info
ATEX
Apr 16, 2026, 4:44 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $40.36
Real-time Price: $80.00 info
Change: +$39.64 (+98%) info
Market Cap: $1.483B info
ATEX
Apr 06, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $38.86
Real-time Price: $80.00 info
Change: +$41.14 (+106%) info
Market Cap: $1.483B info
ATEX
Apr 01, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $38.19
Real-time Price: $80.00 info
Change: +$41.81 (+109%) info
Market Cap: $1.483B info